Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Antispasticity Agents > Larazotide acetate for Sale > Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - large image1
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - image1
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - image2
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - image3
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - image4
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - image5
Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price buy - image6

Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price

TDS 5 Inquiries

Unit Price: Get Latest Price
CAS No.:

881851-50-9

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHANGHAI

Brand:

HyperChem

Packaging:

1kg/Bag, 25kg/drum

Sample Available:

Yes

Price valid (until):

2026-04-11

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Name

    Larazotide

    CAS number

    881851-50-9

    Description

    Larazotide is an investigational, first-in-class octapeptide drug candidate designed to regulate intestinal tight junctions. Chemically known as larazotide acetate.

    Structural formula

     Shop Factory Supply Larazotide Acetate 881851-50-9 with Stable Quality & Competitive Price-Detailed Image 1

    Molecular Formula

    C34H59N9O12

    Molecular Weight

    785.88 g/mol

    Appearance

    White powder

    Quality Standard

    99%

    Storage Condition

    Cool dry place( away from the light)

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag

    Commercial package

    Aluminium Tin, Fiber drum

    Origin

    China

    Larazotide More Info

    Larazotide is an investigational, first-in-class octapeptide drug candidate designed to regulate intestinal tight junctions. Chemically known as larazotide acetate, this synthetic compound consists of eight amino acids (Gly-Gly-Val-Leu-Val-Gln-Pro-Gly) and has a molecular weight of approximately 725.8 g/mol . Its structure is derived from a protein (zonula occludens toxin) secreted by the bacterium Vibrio cholerae, and it shares a conserved motif with the human protein zonulin, which is involved in modulating intestinal permeability . As a non-systemic, gut-restricted agent, larazotide is designed to act locally within the gastrointestinal tract, thereby minimizing potential systemic side effects .

     

    The primary mechanism of action for larazotide is its function as a zonulin receptor antagonist . In conditions like celiac disease, exposure to gluten peptides (gliadin) triggers the release of zonulin from intestinal epithelial cells. Zonulin then initiates a signaling cascade that leads to the disassembly of tight junction protein complexes, increasing paracellular permeability . Larazotide inhibits this process by blocking the putative zonulin receptors on the luminal surface of the small intestine, thereby preventing the breakdown of tight junctions and limiting the trafficking of immunogenic gluten fragments into the lamina propria . More recent research suggests it may also inhibit myosin light chain kinase, which further contributes to stabilizing the tight junction structure .

     

    While initially developed and most extensively studied for celiac disease, recent clinical investigations have revealed potential applications for larazotide beyond this primary indication. A phase 2a trial published in 2025 examined its use in children with multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-COVID-19 inflammatory condition . The study found that larazotide was safe and well-tolerated, and was associated with faster clearance of SARS-CoV-2 spike antigen from circulation, quicker resolution of gastrointestinal symptoms, and an accelerated return to normal activities compared to standard care alone . This therapeutic benefit is hypothesized to result from strengthening intestinal barriers, which limits the translocation of persistent viral particles from the gut into the bloodstream .

     

    The development pathway for larazotide has included multiple clinical trials across phases 1 through 3. Early phase 1 studies focused on establishing safety, tolerance, and pharmacokinetic profiles in both healthy volunteers and patients with controlled celiac disease . Phase 2 trials demonstrated that larazotide could reduce gastrointestinal symptoms and blunt the increase in anti-tissue transglutaminase antibodies following gluten challenge . Subsequently, phase 3 trials were initiated to evaluate its efficacy and safety for relieving persistent symptoms in adult celiac disease patients maintaining a gluten-free diet . According to clinical trial registries, a phase 3 study with 307 participants was conducted, though it was ultimately terminated .

     

    The safety profile of larazotide observed across clinical trials has been generally favorable. In the MIS-C pediatric study, no larazotide-related adverse events were reported, and the drug was well tolerated at the dosing regimen of 10 mcg/kg (maximum 500 mcg/dose) four times daily for three weeks . Its gut-restricted nature as a non-systemic, intestine-targeted peptide is considered a valuable characteristic, as therapeutic activity is concentrated within the gastrointestinal tract while the risk for systemic exposure and whole-body toxicities is diminished . This safety profile supports ongoing research into larazotide for additional conditions where barrier dysfunction plays a pathogenic role, including potential applications in type 1 diabetes and long COVID .


    Package Image

    Shop High Quality Oxytocin CAS 50-56-6-Detailed Image 2

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3



    FAQ

    Q1. Can I get a free sample?

    We can send you a samll free sample, and you only need to pay for the shipping cost.


    Q2. What is the HyperChem payment term?

    T/T in advance
    LC at sight
    DP at sight

    Bank transfer

    PayPal

    Bitcoin...


    Q3. What is HyperChem shipment policy?

    Our policy is to strive for the quickest shipment time possible.

    For ready stock samples, they are usually shipped within 3 working days after payment received.
    For non-ready stock, please contact HyperChem sales team to negotiate.


    Q4. What is HyperChem shipment term?

    By Express  
    FedEx  UPS  DHL  EMS                               
    Fast: 3-7 days around, high cost, door to door service

    By Air                                        
    Suitable for more than 50kg 
    Fast: 3-7 days, hight cost, port to port, professional broker needed 

    By Sea
    Suitable for more than 500kg      
    Fast: 7-45 days, low cost, port to port, professional broker needed 


    We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.


    Q5. What HyperChem will provide after shipment?

    For sample orders: 
    After shipment is done, an timely email including:

    1. Track details (Fedex /TNT/DHL/EMS Track number)
    2. Packaging photo
    3. COA, MSDS, etc
    4. Dispatch date & Estimated arriving time
    5. Shipping invoice

    For commercial orders
    A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.



    Company Profile

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.


    Among them, our key client industrial sectors around the global are:

    Pharmaceuticals
    Nutrition Ingredients/ Dietary supplements
    Cosmetic Ingredients
    Food Ingredients
    Veterinary API
    Agriculture fertilizer
    Custom Synthesis lab supply


    HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.




    Certificates

    Basic Info
    Product Name:

    Larazotide acetate

    Other Name:

    H-GLY-GLY-VAL-LEU-VAL-GLN-PRO-GLY-OH;Larazotide acetate;LARAZOTIDE ACETATE (> 90%);inhibit,Larazotide acetate,Larazotide,Inhibitor,Gap Junction Protein;Larazotide acetate salt;AT-1001 (Larazotide acetate);GGVLVQPG

    CAS No.:

    881851-50-9

    Molecular Formula:

    C34H59N9O12

    InChIKeys:

    NYGCNONRVCGHAT-FTIBEKKFNA-N

    Molecular Weight:

    785.88536

    Color/Form:

    White

    Categories:

    Antispasticity Agents

    Characteristics
    Melting Point:

    >231°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Company Certificates
    • Hangzhou Hyper Chemicals LimitedCertification Report by Bureau Veritas Certification Report by Bureau Veritas
    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    5 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    Larazotide acetate

    10 MG Oct 7, 2026
    Canada

    Larazotide

    5 G Jan 26, 2026
    Brazil

    Larazotide Acetate

    400 MG Dec 24, 2025
    United Kingdom

    Pharma Chemical Peptides vials powder Larazotide Acetate

    1 G May 28, 2024
    United Kingdom

    Pharma Chemical Peptides vials powder Larazotide Acetate

    1 G May 22, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.